(S (PP (IN As) (NP (DT a) (ADJP (RB highly) (JJ infectious)) (JJ respiratory) (NN disease))) (, ,) (NP (NN COVID) (HYPH -) (CD 19)) (VP (VBZ has) (VP (VBN become) (NP (NP (DT a) (NN pandemic)) (SBAR (WHNP (WDT that)) (S (VP (VBZ threatens) (NP (JJ global) (NN health)))))))) (. .))
(S (PP (IN Without) (NP (DT an) (JJ effective) (NN treatment))) (, ,) (NP (NP (JJ non-pharmaceutical) (NNS interventions)) (, ,) (PP (JJ such) (IN as) (NP (NN travel) (NNS restrictions))) (, ,)) (VP (VBP have) (VP (VBN been) (ADVP (RB widely)) (VP (VBN promoted) (S (VP (TO to) (VP (VB mitigate) (NP (DT the) (NN outbreak)))))))) (. .))
(S (S (NP (JJ Current) (NNS studies)) (VP (VBP analyze) (NP (NP (NN mobility) (NNS metrics)) (PP (JJ such) (IN as) (NP (NN travel) (NN distance)))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (NP (NN research)) (PP (IN on) (NP (JJ interzonal) (NN travel) (NN flow)))) (CC and) (NP (NP (PRP$ its) (NN impact)) (PP (IN on) (NP (DT the) (NN pandemic))))))))) (. .))
(S (NP (PRP$ Our) (NN study)) (ADVP (RB specifically)) (VP (VBZ focuses) (PP (IN on) (NP (NP (DT the) (JJ inter-county) (NN mobility) (NN pattern)) (CC and) (NP (PRP$ its) (NN influence)))) (PP (IN on) (NP (NP (DT the) (NML (NN COVID) (HYPH -) (CD 19)) (NN spread)) (PP (IN in) (NP (DT the) (NNP United) (NNP States)))))) (. .))
(S (S (VP (TO To) (VP (VB retrieve) (NP (NML (JJ real) (HYPH -) (NN world)) (NN mobility) (NNS patterns))))) (, ,) (NP (PRP we)) (VP (VBP utilize) (NP (NP (DT an) (VBN integrated) (NN set)) (PP (IN of) (NP (NML (JJ mobile) (NN device)) (NN location) (NNS data)))) (PP (VBG including) (PP (IN over) (NP (QP (CD 100) (CD million)) (JJ anonymous) (NNS devices))))) (. .))
(S (NP (PRP We)) (ADVP (RB first)) (VP (VB investigate) (NP (NP (DT the) (JJ nationwide) (JJ temporal) (NN trend)) (CC and) (NP (NP (JJ spatial) (NN distribution)) (PP (IN of) (NP (JJ inter-county) (NN mobility)))))) (. .))
(S (ADVP (RB Then)) (NP (PRP we)) (VP (VP (VBP zoom) (PP (IN in) (PP (IN on) (NP (NP (DT the) (NN epicenter)) (PP (IN of) (NP (NP (DT the) (NNP U.S.) (NN outbreak)) (, ,) (NP (NML (NNP New) (NNP York)) (NNP City)) (, ,))))))) (CC and) (VP (VB evaluate) (NP (NP (DT the) (NNS impacts)) (PP (IN of) (NP (PRP$ its) (NN outflow)))) (PP (IN on) (NP (JJ other) (NNS counties))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP develop) (NP (NP (DT a) (`` ") (NML (NML (NN log)) (SYM -) (NML (JJ linear) (JJ double) (HYPH -) (NN risk))) ('' ") (NN model)) (PP (IN at) (NP (DT the) (NN county) (NN level)))) (S (VP (TO to) (VP (VB quantify) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (CC both) (NP (NP (`` ") (JJ external) (NN risk) ('' ")) (VP (VBN imported) (PP (IN by) (NP (NP (JJ inter-county) (NN mobility)) (SBAR (S (VP (VBZ flows)))))))) (CC and) (NP (NP (DT the) (`` ") (JJ internal) (NN risk) ('' ")) (VP (VBN defined) (PP (IN as) (NP (NP (DT the) (NN vulnerability)) (PP (IN of) (NP (NP (DT a) (NN county)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN population))))))))) (PP (IN with) (NP (NML (JJ high) (HYPH -) (NN risk)) (NNS phenotypes)))))))))))) (. .))
(S (NP (PRP$ Our) (NN study)) (VP (VP (VBZ enhances) (NP (NP (DT the) (NN situation) (NN awareness)) (PP (IN of) (NP (JJ inter-county) (NN mobility)))) (PP (IN in) (NP (DT the) (NNP U.S.)))) (CC and) (VP (MD can) (VP (VB help) (S (VP (VB improve) (NP (JJ non-pharmaceutical) (NNS interventions)) (PP (IN for) (NP (NN COVID) (HYPH -) (CD 19)))))))) (. .))
